Retraction: Modulatory Role of PYY in Transport and Metabolism of Cholesterol in Intestinal Epithelial Cells (PLoS ONE 7: 7 (e40992) DOI: 10.1371/journal.pone.0040992);Modulatory role of PYY in transport and metabolism of cholesterol in intestinal epithelial cells

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Grenier, Emilie ^a,b   Garofalo, Carole ^a   Delvin, Edgard ^a,b   Levy, Emile ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; CARBON 14; CELL PROTEIN; CHOLESTEROL; CHYLOMICRON; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; METHIONINE; NIEMANN PICK C1 LIKE 1 PROTEIN; OLEIC ACID; PEPTIDE YY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; RETINOID X RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SULFUR 35; UNCLASSIFIED DRUG;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; BIOGENESIS; CELL STRAIN CACO 2; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LIPID METABOLISM; POLYMERASE CHAIN REACTION; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; WESTERN BLOTTING;

EID: 84864229924     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0267059     Document Type: Erratum

References (84)

1. Arantes RM, Nogueira AM, (1997) Distribution of enteroglucagon- and peptide YY-immunoreactive cells in the intestinal mucosa of germ-free and conventional mice. Cell Tissue Res 290: 61-69.
2. Bottcher G, Sjolund K, Ekblad E, Hakanson R, Schwartz TW, et al. (1984) Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept 8: 261-266.
3. Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, et al. (2005) Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 146: 5120-5127.
4. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, et al. (1994) Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51: 151-159.
5. Ueno H, Yamaguchi H, Mizuta M, Nakazato M, (2008) The role of PYY in feeding regulation. Regul Pept 145: 12-16.
6. Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, et al. (1985) Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89: 494-499.
7. Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR, (1987) Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 28: 166-170.
8. Spiller RC, Trotman IF, Adrian TE, Bloom SR, Misiewicz JJ, et al. (1988) Further characterisation of the 'ileal brake' reflex in man-effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 29: 1042-1051.
9. Armstrong DN, Krenz HK, Modlin IM, Ballantyne GH, (1993) Bile salt inhibition of motility in the isolated perfused rabbit terminal ileum. Gut 34: 483-488.
10. Lin HC, Zhao XT, Wang L, Wong H, (1996) Fat-induced ileal brake in the dog depends on peptide YY. Gastroenterology 110: 1491-1495.
11. Cuche G, Cuber JC, Malbert CH, (2000) Ileal short-chain fatty acids inhibit gastric motility by a humoral pathway. Am J Physiol Gastrointest Liver Physiol 279: G925-G930.
12. Aponte GW, (2002) PYY-mediated fatty acid induced intestinal differentiation. Peptides 23: 367-376.
13. Pironi L, Stanghellini V, Miglioli M, Corinaldesi R, De GR, et al. (1993) Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 105: 733-739.
14. Van Citters GW, Lin HC, (2006) Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 8: 367-373.
15. Hallden G, Hadi M, Hong HT, Aponte GW, (1999) Y receptor-mediated induction of CD63 transcripts, a tetraspanin determined to be necessary for differentiation of the intestinal epithelial cell line, hBRIE 380i cells. J Biol Chem 274: 27914-27924.
16. Jump DB, Clarke SD, (1999) Regulation of gene expression by dietary fat. Annu Rev Nutr 19: 63-90.
17. Boey D, Sainsbury A, Herzog H, (2007) The role of peptide YY in regulating glucose homeostasis. Peptides 28: 390-395.
18. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, et al. (2006) Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 4: 223-233.
19. Hanusch-Enserer U, Ghatei MA, Cauza E, Bloom SR, Prager R, et al. (2007) Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery. Wien Klin Wochenschr 119: 291-296.
20. Cahill F, Shea JL, Randell E, Vasdev S, Sun G, (2011) Serum peptide YY in response to short-term overfeeding in young men. Am J Clin Nutr 93: 741-747.
21. Levy E, Mehran M, Seidman E, (1995) Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J 9: 626-635.
22. Liu CD, Newton TR, Zinner MJ, Ashley SW, McFadden DW, (1997) Intraluminal peptide YY induces colonic absorption in vivo. Dis Colon Rectum 40: 478-482.
23. Liu CD, Hines OJ, Whang EE, Balasubramaniam A, Newton TR, et al. (1995) A novel synthetic analog of peptide YY, BIM-43004, given intraluminally, is proabsorptive. J Surg Res 59: 80-84.
24. Brodish RJ, Kuvshinoff BW, Fink AS, McFadden DW, (1992) Effects of intraluminal peptide YY on pancreatic function. Int J Pancreatol 12: 153-160.
25. McFadden DW, Rudnicki M, Nussbaum MS, Balasubramaniam A, Fischer JE, (1989) Independent release of peptide YY (PYY) into the circulation and ileal lumen of the awake dog. J Surg Res 46: 380-385.
26. Beaulieu JF, Quaroni A, (1991) Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells. Biochem J 280 (Pt 3): 599-608.
27. Vachon PH, Beaulieu JF, (1992) Transient mosaic patterns of morphological and functional differentiation in the Caco-2 cell line. Gastroenterology 103: 414-423.
28. Vachon PH, Perreault N, Magny P, Beaulieu JF, (1996) Uncoordinated, transient mosaic patterns of intestinal hydrolase expression in differentiating human enterocytes. J Cell Physiol 166: 198-207.
29. Grenier E, Maupas FS, Beaulieu JF, Seidman E, Delvin E, et al. (2007) Effect of retinoic acid on cell proliferation and differentiation as well as on lipid synthesis, lipoprotein secretion, and apolipoprotein biogenesis. Am J Physiol Gastrointest Liver Physiol 293: G1178-G1189.
30. Sane AT, Sinnett D, Delvin E, Bendayan M, Marcil V, et al. (2006) Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res 47: 2112-2120.
31. Schmitz J, Kahlke W, (1973) [Serum lipoproteins and lipids in patients with hepatitis (author's transl)]. Dtsch Med Wochenschr 98: 2436-2439.
32. Ravid Z, Bendayan M, Delvin E, Sane AT, Elchebly M, et al. (2008) Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors. Am J Physiol Gastrointest Liver Physiol 295: G873-G885.
33. Mailhot G, Ravid Z, Barchi S, Moreau A, Rabasa-Lhoret R, et al. (2009) CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells. Am J Physiol Gastrointest Liver Physiol 297: G1239-G1249.
34. Marcil V, Delvin E, Garofalo C, Levy E, (2003) Butyrate impairs lipid transport by inhibiting microsomal triglyceride transfer protein in Caco-2 cells. J Nutr 133: 2180-2183.
35. Montoudis A, Delvin E, Menard D, Beaulieu JF, Jean D, et al. (2006) Intestinal-fatty acid binding protein and lipid transport in human intestinal epithelial cells. Biochem Biophys Res Commun 339: 248-254.
36. Pshezhetsky AV, Fedjaev M, Ashmarina L, Mazur A, Budman L, et al. (2007) Subcellular proteomics of cell differentiation: quantitative analysis of the plasma membrane proteome of Caco-2 cells. Proteomics 7: 2201-2215.
37. Slight I, Bendayan M, Malo C, Delvin E, Lambert M, et al. (2004) Identification of microsomal triglyceride transfer protein in intestinal brush-border membrane. Exp Cell Res 300: 11-22.
38. Levy E, Menard D, Suc I, Delvin E, Marcil V, et al. (2004) Ontogeny, immunolocalisation, distribution and function of SR-BI in the human intestine. J Cell Sci 117: 327-337.
39. Playford RJ, Domin J, Beacham J, Parmar KB, Tatemoto K, et al. (1990) Preliminary report: role of peptide YY in defence against diarrhoea. Lancet 335: 1555-1557.
40. Cox HM, Tough IR, (2002) Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa. Br J Pharmacol 135: 1505-1512.
41. Witte AB, Gryback P, Holst JJ, Hilsted L, Hellstrom PM, et al. (2009) Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. Regul Pept 158: 57-62.
42. Yakovich AJ, Huang Q, Du J, Jiang B, Barnard JA, (2010) Vectorial TGFbeta signaling in polarized intestinal epithelial cells. J Cell Physiol 224: 398-404.
43. Sonnier DI, Bailey SR, Schuster RM, Lentsch AB, Pritts TA, (2010) TNF-alpha induces vectorial secretion of IL-8 in Caco-2 cells. J Gastrointest Surg 14: 1592-1599.
44. Peretti N, Delvin E, Sinnett D, Marcil V, Garofalo C, et al. (2007) Asymmetrical regulation of scavenger receptor class B type I by apical and basolateral stimuli using Caco-2 cells. J Cell Biochem 100: 421-433.
45. Sgambati SA, Turowski GA, Basson MD, (1997) Peptide YY selectively stimulates expression of the colonocytic phenotype. J Gastrointest Surg 1: 561-568.
46. Sonoyama K, Suzuki K, Kasai T, (2000) Peptide YY stimulates the expression of apolipoprotein A-IV gene in Caco-2 intestinal cells. Proc Soc Exp Biol Med 223: 270-275.
47. Kalogeris TJ, Qin X, Chey WY, Tso P, (1998) PYY stimulates synthesis and secretion of intestinal apolipoprotein AIV without affecting mRNA expression. Am J Physiol 275: G668-G674.
48. Mannon PJ, Mele JM, (2000) Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor. Biochem J 350 Pt 3: 655-661.
49. Cox HM, Tough IR, (1995) Functional characterization of receptors with affinity for PYY, NPY, [Leu31,Pro34]NPY and PP in a human colonic epithelial cell line. Br J Pharmacol 116: 2673-2678.
50. Cheng MH, Bushnell D, Cannon DT, Kern M, (2009) Appetite regulation via exercise prior or subsequent to high-fat meal consumption. Appetite 52: 193-198.
51. Zwirska-Korczala K, Sodowski K, Konturek SJ, Kuka D, Kukla M, et al. (2008) Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome. J Physiol Pharmacol 59: 161-178.
52. Pasman WJ, Heimerikx J, Rubingh CM, van den Berg R, O'Shea M, et al. (2008) The effect of Korean pine nut oil on in vitro CCK release, on appetite sensations and on gut hormones in post-menopausal overweight women. Lipids Health Dis 7: 10.
53. Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, et al. (2005) Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY. Eur J Gastroenterol Hepatol 17: 207-212.
54. Ballantyne GH, (2006) Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions. Obes Surg 16: 651-658.
55. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, et al. (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303: 1201-1204.
56. van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, et al. (2005) Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res 46: 526-534.
57. Valasek MA, Clarke SL, Repa JJ, (2007) Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse. J Lipid Res 48: 2725-2735.
58. Repa JJ, Mangelsdorf DJ, (2002) The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 8: 1243-1248.
59. Duval C, Touche V, Tailleux A, Fruchart JC, Fievet C, et al. (2006) Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem Biophys Res Commun 340: 1259-1263.
60. Ge L, Qi W, Wang LJ, Miao HH, Qu YX, et al. (2011) Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake. Proc Natl Acad Sci U S A 108: 551-556.
61. Clarke CF, Edwards PA, Lan SF, Tanaka RD, Fogelman AM, (1983) Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA levels in rat liver. Proc Natl Acad Sci U S A 80: 3305-3308.
62. Liscum L, Luskey KL, Chin DJ, Ho YK, Goldstein JL, et al. (1983) Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and its mRNA in rat liver as studied with a monoclonal antibody and a cDNA probe. J Biol Chem 258: 8450-8455.
63. Jakoi L, Quarfordt SH, (1974) The induction of hepatic cholesterol synthesis in the rat by lecithin mesophase infusions. J Biol Chem 249: 5840-5844.
64. Kirsten ES, Watson JA, (1974) Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in hepatoma tissue culture cells by serum lipoproteins. J Biol Chem 249: 6104-6109.
65. Chang TY, Limanek JS, Chang CC, (1981) Evidence indicating that inactivation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by low density lipoprotein or by 25-hydroxycholesterol requires mediator protein(s) with rapid turnover rate. J Biol Chem 256: 6174-6180.
66. Faust JR, Luskey KL, Chin DJ, Goldstein JL, Brown MS, (1982) Regulation of synthesis and degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by low density lipoprotein and 25-hydroxycholesterol in UT-1 cells. Proc Natl Acad Sci U S A 79: 5205-5209.
67. Richert L, Castagna M, Beck JP, Rong S, Luu B, et al. (1984) Growth-rate-related and hydroxysterol-induced changes in membrane fluidity of cultured hepatoma cells: correlation with 3-hydroxy-3-methyl glutaryl CoA reductase activity. Biochem Biophys Res Commun 120: 192-198.
68. Roitelman J, Shechter I, (1984) Regulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase. Evidence for thiol-dependent allosteric modulation of enzyme activity. J Biol Chem 259: 870-877.
69. Volpe JJ, Obert KA, (1981) Cytoskeletal structures and 3-hydroxy-3-methylglutaryl coenzyme A reductase in C-6 glial cells. A role for microfilaments. J Biol Chem 256: 2016-2021.
70. Lehrer G, Panini SR, Rogers DH, Rudney H, (1981) Modulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase by lipid inhibitors, substrates, and cytosolic factors. J Biol Chem 256: 5612-5619.
71. Fisher EA, Zhou M, Mitchell DM, Wu X, Omura S, et al. (1997) The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J Biol Chem 272: 20427-20434.
72. Yeung SJ, Chen SH, Chan L, (1996) Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B. Biochemistry 35: 13843-13848.
73. Fu-Cheng X, Souli A, Chariot J, Roze C, (1999) Antisecretory effect of peptide YY through neural receptors in the rat jejunum in vitro. Peptides 20: 987-993.
74. Servin AL, Rouyer-Fessard C, Balasubramaniam A, Saint PS, Laburthe M, (1989) Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3′,5′-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors. Endocrinology 124: 692-700.
75. Wren AM, Bloom SR, (2007) Gut hormones and appetite control. Gastroenterology 132: 2116-2130.
76. Ahren B, (2003) Gut peptides and type 2 diabetes mellitus treatment. Curr Diab Rep 3: 365-372.
77. Drucker DJ, (2007) The role of gut hormones in glucose homeostasis. J Clin Invest 117: 24-32.
78. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, et al. (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244: 741-749.
79. Zwirska-Korczala K, Konturek SJ, Sodowski M, Wylezol M, Kuka D, et al. (2007) Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol 58: 13-35.
80. Velhote MC, Damiani D, (2010) Bariatric surgery in adolescents: preliminary 1-year results with a novel technique (Santoro III). Obes Surg 20: 1710-1715.
81. Jones TE, Basilio JL, Brophy PM, McCammon MR, Hickner RC, (2009) Long-term exercise training in overweight adolescents improves plasma peptide YY and resistin. Obesity (Silver Spring) 17: 1189-1195.
82. Sanchez D, Miguel M, Aleixandre A, (2012) Dietary fiber, gut peptides, and adipocytokines. J Med Food 15: 223-230.
83. Walther C, Morl K, Beck-Sickinger AG, (2011) Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development. J Pept Sci 17: 233-246.
84. Gicquiaux H, Lecat S, Gaire M, Dieterlen A, Mely Y, et al. (2002) Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. J Biol Chem 277: 6645-6655.